Skip to main content
PharmAbcine Inc. logo

PharmAbcine Inc. — Investor Relations & Filings

Ticker · 208340 ISIN · KR7208340000 KO Manufacturing
Open in API
Filings indexed 461 across all filing types
Latest filing 2018-12-03 Regulatory Filings
Country KR South Korea
Listing KO 208340

About PharmAbcine Inc.

http://pharmabcine.com/

PharmAbcine Inc. is a clinical-stage biotechnology company specializing in the development of fully human therapeutic monoclonal antibodies (mAbs). The company focuses on creating innovative treatments for diseases with high unmet medical needs, primarily in oncology, neovascular eye diseases, and other inflammatory and vascular disorders. Utilizing its proprietary human antibody library and discovery technologies, PharmAbcine advances a pipeline of next-generation IgG-based therapeutics. The company's mission is to contribute to human health by providing novel antibody-based drugs to patients.

Recent filings

Filing Released Lang Actions
기타경영사항(특허권취득)(자율공시)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent (특허권 취득) by the company PharmAbcine. It details the patent name, content, and utilization plan. Since it does not fit into specific categories like financial reports, M&A, or director dealings, and is a standard regulatory disclosure of corporate events, it falls under the general regulatory filing category.
2018-12-03 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea under the Financial Investment Services and Capital Markets Act. This document is used to notify the market when an entity or individual crosses a significant ownership threshold (typically 5%) in a listed company. Based on the provided filing categories, this fits the definition of a 'Major Shareholding Notification' (MRQ).
2018-11-29 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status of (주)네오플럭스 in (주)파멥신 following a KOSDAQ listing. This type of filing is specifically used to notify the market when an entity crosses a significant ownership threshold (5% in this case). Since it is a formal regulatory disclosure of share ownership rather than a general announcement, it falls under the 'Major Shareholding Notification' category.
2018-11-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the share ownership status of major shareholders (including the CEO and executives) of the company '(주)파멥신' (PharmAbcine) following its KOSDAQ listing. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2018-11-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form used in South Korea for reporting insider transactions and share ownership changes by company directors and major shareholders. Based on the provided definitions, this corresponds to 'Director's Dealing' (DIRS), which covers personal share transactions by company directors and executives.
2018-11-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when a company director or major shareholder changes their shareholding position. This corresponds to the 'Director's Dealing' category (DIRS) in the provided classification schema.
2018-11-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.